Brilliant Stain Buffer

The BD Horizon™ Brilliant Stain Buffer is a buffer for the immunofluorescent staining of cells. Brilliant Stain Buffer is a solution that is added to mixtures of certain fluorescent reagents before staining cells. It was designed to complement multicolor flow cytometry experiments that utilize staining reagents conjugated with BD Horizon Brilliant fluorescent polymer dyes. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime BD Horizon Brilliant dyes are used. The BD Horizon Brilliant Stain Buffer is compatible with the use of other fluorescent staining reagents conjugated with traditional fluorochromes, such as fluorescein, phycoerythrin or Alexa Fluor® dyes.

The BD Horizon™ Brilliant Stain Buffer is a buffer for the immunofluorescent staining of cells. Brilliant Stain Buffer is a solution that is added to mixtures of certain fluorescent reagents before staining cells. It was designed to complement multicolor flow cytometry experiments that utilize staining reagents conjugated with BD Horizon Brilliant fluorescent polymer dyes. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime BD Horizon Brilliant dyes are used. The BD Horizon Brilliant Stain Buffer is compatible with the use of other fluorescent staining reagents conjugated with traditional fluorochromes, such as fluorescein, phycoerythrin or Alexa Fluor® dyes.

Aqueous buffered solution containing BSA and ≤0.09% sodium azide.

Development References(7) 1. Acosta JR, Douagi I, Andersson DP, et al. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes.. Diabetologia. 2016; 59(3):560-70. (Methodology). 2. Andrés-Blasco I, Herrero-Cervera A, Vinué Á, et al. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.. J Endocrinol. 2015; 227(3):179-91. (Methodology). 3. Ingelman-Sundberg HM, Laestadius Å, Chrapkowska C, et al. Diverse effects on vaccine-specific serum IgG titres and memory B cells upon methotrexate and anti-TNF-α therapy in children with rheumatic diseases: A cross-sectional study.. Vaccine. 2016; 34(10):1304-11. (Methodology: Flow cytometry). 4. Leijten EF, van Kempen TS, Boes M, et al. Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid.. 2015; 67(10):2673-8. (Methodology: Flow cytometry). 5. McKay FC, Gatt PN, Fewings N, et al. The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.. Clin Immunol. 2016; 163:96-107. (Methodology: Flow cytometry). 6. O'Connor KS, Read SA, Wang M, et al. IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection.. Genes Immun. 2016; 17(6):328-34. (Methodology: Flow cytometry). 7. Vinué Á, Andrés-Blasco I, Herrero-Cervera A, et al. Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling.. Biochim Biophys Acta. 2015; 1852(9):1729-42. (Methodology: Flow cytometry).